Skip to main content

GSA CAPITAL PARTNERS LLP

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1362033 LONDON, X0

Position in XERS

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$588,340
+$316,220 QoQ
Shares Held
101,438
+192.6% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $10,668,998 across 16 Drug Manufacturers - Specialty & Generic names. XERS ranks #7 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 XERS
Xeris Biopharma Holdings, Inc.
This page
101,438 $588,340

All Filings in XERS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $588,340 101,438
2025-12-31 $272,120 34,665
2025-09-30 $559,348 68,716
2025-06-30 $291,043 62,322
2025-03-31 $761,655 138,735
2024-12-31 $168,967 49,843
2024-09-30 $77,947 27,350
2024-06-30 $1,362,741 605,663
2024-03-31 $25,881 11,711
2023-12-31 $978,227 416,267
2023-09-30 $709,089 381,231
2023-06-30 $87,023 33,215
2023-03-31 $515,120 316,025
2022-09-30 $78,146 50,094
2022-06-30 $68,739 44,636
2022-03-31 $300,305 117,307
2021-12-31 $326,026 111,272